These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33588752)

  • 1. Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.
    Lekholm E; Ceder MM; Forsberg EC; Schiöth HB; Fredriksson R
    Cell Mol Biol Lett; 2021 Feb; 26(1):5. PubMed ID: 33588752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.
    Janz R; Südhof TC
    Neuroscience; 1999; 94(4):1279-90. PubMed ID: 10625067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment.
    Iezzi M; Theander S; Janz R; Loze C; Wollheim CB
    J Cell Sci; 2005 Dec; 118(Pt 23):5647-60. PubMed ID: 16306227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.
    Crèvecoeur J; Kaminski RM; Rogister B; Foerch P; Vandenplas C; Neveux M; Mazzuferi M; Kroonen J; Poulet C; Martin D; Sadzot B; Rikir E; Klitgaard H; Moonen G; Deprez M
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):191-204. PubMed ID: 23617838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
    Bajjalieh SM; Frantz GD; Weimann JM; McConnell SK; Scheller RH
    J Neurosci; 1994 Sep; 14(9):5223-35. PubMed ID: 8083732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE; Mochida S; Kensel-Hammes P; Custer KL; Bajjalieh SM
    Mol Cell Neurosci; 2005 May; 29(1):56-64. PubMed ID: 15866046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the In Vivo Specificity of [
    Serrano ME; Becker G; Bahri MA; Seret A; Mestdagh N; Mercier J; Mievis F; Giacomelli F; Lemaire C; Salmon E; Luxen A; Plenevaux A
    Molecules; 2019 May; 24(9):. PubMed ID: 31052478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).
    Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD
    Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance.
    Stout KA; Dunn AR; Hoffman C; Miller GW
    ACS Chem Neurosci; 2019 Sep; 10(9):3927-3938. PubMed ID: 31394034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV2B regulates synaptotagmin 1 by direct interaction.
    Lazzell DR; Belizaire R; Thakur P; Sherry DM; Janz R
    J Biol Chem; 2004 Dec; 279(50):52124-31. PubMed ID: 15466855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic vesicle protein 2b is expressed temporospatially in (pre)odontoblasts in developing molars.
    Yang SY; Jeon SK; Kang JH; Yoo HI; Kim YS; Moon JS; Kim MS; Koh JT; Oh WM; Kim SH
    Eur J Oral Sci; 2012 Dec; 120(6):505-12. PubMed ID: 23167466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.
    Peng C; Zhu G; Liu X; Li H
    Neurosci Bull; 2018 Oct; 34(5):747-758. PubMed ID: 29713895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina.
    Wang MM; Janz R; Belizaire R; Frishman LJ; Sherry DM
    J Comp Neurol; 2003 May; 460(1):106-22. PubMed ID: 12687700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.
    Venkatesan K; Alix P; Marquet A; Doupagne M; Niespodziany I; Rogister B; Seutin V
    J Neurosci Res; 2012 Dec; 90(12):2317-27. PubMed ID: 22847229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system.
    Dardou D; Dassesse D; Cuvelier L; Deprez T; De Ryck M; Schiffmann SN
    Brain Res; 2011 Jan; 1367():130-45. PubMed ID: 20869353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SV2 isoforms during rodent brain development.
    Crèvecœur J; Foerch P; Doupagne M; Thielen C; Vandenplas C; Moonen G; Deprez M; Rogister B
    BMC Neurosci; 2013 Aug; 14():87. PubMed ID: 23937191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.
    Lynch JM; Tate SK; Kinirons P; Weale ME; Cavalleri GL; Depondt C; Murphy K; O'Rourke D; Doherty CP; Shianna KV; Wood NW; Sander JW; Delanty N; Goldstein DB; Sisodiya SM
    Epilepsy Res; 2009 Jan; 83(1):44-51. PubMed ID: 18977120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain contains two forms of synaptic vesicle protein 2.
    Bajjalieh SM; Peterson K; Linial M; Scheller RH
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2150-4. PubMed ID: 7681585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.